Olema Pharmaceuticals, Inc.
OLMACIK 0001750284 · Every Form 4 filed by insiders at this issuer.
Filings
12
Latest Mar 29, 2024
Unique insiders
6
Showing
12 of 12
Page 1
Top insiders
Most active reporters at Olema Pharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| Harmon Cyrus | Director | 4 |
| Zojwalla Naseem | Officer | 3 |
| Kovacs Shane William Charles | Officer | 2 |
| Bohen Sean | OfficerDirector | 1 |
| Myles David C. | Officer | 1 |
| RAPPAPORT ANDREW | Director | 1 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 29, 2024 | Harmon Cyrus Director | S | 20,000 | $10.97 | $219,400 | |
| Mar 20, 2024 | Zojwalla Naseem CHIEF MEDICAL OFFICER | M | 13,700 | $4.87 | $66,719 | |
| Mar 6, 2024 | RAPPAPORT ANDREW Director | J | 481,014 | $0.00 | $0 | |
| Mar 4, 2024 | Harmon Cyrus Director | S | 24,900 | $12.41 | $309,009 | |
| Feb 5, 2024 | Bohen Sean PRESIDENT AND CEO · Director | Holdings only | — | — | — | |
| Feb 5, 2024 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Holdings only | — | — | — | |
| Feb 5, 2024 | Zojwalla Naseem CHIEF MEDICAL OFFICER | Holdings only | — | — | — | |
| Feb 5, 2024 | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Holdings only | — | — | — | |
| Feb 2, 2024 | Harmon Cyrus Director | S | 25,000 | $12.23 | $305,750 | |
| Jan 29, 2024 | Zojwalla Naseem CHIEF MEDICAL OFFICER | M | 20,000 | $7.02 | $140,400 | |
| Jan 16, 2024 | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | M | 50,000 | $7.02 | $351,000 | |
| Jan 2, 2024 | Harmon Cyrus Director | S | 22,500 | $13.30 | $299,250 |
Showing 1–12 of 12
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.